Page last updated: 2024-08-23

phosphotyrosine and Disease Exacerbation

phosphotyrosine has been researched along with Disease Exacerbation in 16 studies

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's9 (56.25)29.6817
2010's5 (31.25)24.3611
2020's2 (12.50)2.80

Authors

AuthorsStudies
Choi, JH; Hwang, YE; Jeong, J; Kang, T; Keum, S; Kim, JW; Park, D; Park, E; Rhee, S; Yang, SJ1
Chen, A; Cheng, ML; Hung, LM; Jiang, B; Li, Q; Li, X; Lin, D; Lin, F; Ma, H; Shih, LM; Suleman, M; Sun, D; Tang, HY; Tsau, MT; Wen, S; Xie, C; Zhang, F; Zhang, J; Zhao, W; Zhou, L1
Deng, Y; Ding, Q; He, K; Li, H; Mu, G; Wu, L; Xu, M; Yang, D; Yu, H; Zhang, L; Zhou, J1
Ahn, R; Cory, S; Ha, JR; Hallett, M; Hardy, WR; Im, YK; Maric, G; Park, M; Pawson, T; Sabourin, V; Siegel, PM; Ursini-Siegel, J; Zhao, H1
Rapp, UR; Sperl, B; Ulaganathan, VK; Ullrich, A1
de la Cueva, A; Kirsch, KH; Kumbrink, J; Sailer, N; Soni, S1
Basu, N; Bhandari, R; Natarajan, VT; Visweswariah, SS1
Freydin, B; Hooke, JA; Hyslop, T; Klimowicz, AC; Kovatich, AJ; Liu, C; Magliocco, AM; Nevalainen, MT; Peck, AR; Pequignot, E; Rimm, DL; Rosenberg, AL; Rui, H; Sauter, G; Shriver, CD; Stringer, GA; Tran, TH; Witkiewicz, AK; Yang, N1
Bergin, O; Dervan, PA; Easty, DJ; Fallowfield, ME; McArdle, L1
Kulkarni, S; Levitsky, P; Malovani, H; Nir, U; Parris, W; Pawson, T; Perry, E; Pomp, O; Shpungin, S; Taller, M; Tsruya, R; Weisberg, S1
Attems, J; Czerwenka, K; Gschwantler-Kaulich, D; Hoschützky, H; Huber, I; Hudelist, G; Köstler, WJ; Kubista, E; Manavi, M; Müller, R; Singer, CF; Zielinski, CC1
Buchanan, FG; DuBois, RN; Gorden, DL; Matrisian, LM; Matta, P; Shi, Q1
Earp, HS; Liu, Y; Mahajan, NP; Majumder, S; Mohler, JL; Parker, CE; Warren, MR; Whang, YE1
Chen, CS; Chen, Y; Choong, LY; Druker, BJ; Hande, MP; Lim, S; Lim, YP; Loh, MC; Man, X; Pan, M; Poonepalli, A; Salto-Tellez, M; Shah, N; Tan, PH; Toy, W; Wong, CY1
McKeehan, K; McKeehan, WL; Wang, F; Yu, C1
Bolay, H; Can, A; Dalkara, T; Gürsoy-Ozdemir, Y; Onur, R; Sara, Y1

Trials

1 trial(s) available for phosphotyrosine and Disease Exacerbation

ArticleYear
Her-2/neu and EGFR tyrosine kinase activation predict the efficacy of trastuzumab-based therapy in patients with metastatic breast cancer.
    International journal of cancer, 2006, Mar-01, Volume: 118, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibody Specificity; Breast Neoplasms; Disease Progression; Enzyme Activation; ErbB Receptors; Gene Expression Regulation, Neoplastic; Humans; Immunotherapy; Middle Aged; Neoplasm Metastasis; Peptides; Phosphotyrosine; Prognosis; Receptor, ErbB-2; Survival Rate; Trastuzumab

2006

Other Studies

15 other study(ies) available for phosphotyrosine and Disease Exacerbation

ArticleYear
Beta-Pix-dynamin 2 complex promotes colorectal cancer progression by facilitating membrane dynamics.
    Cellular oncology (Dordrecht), 2021, Volume: 44, Issue:6

    Topics: Amino Acid Sequence; Cell Line, Tumor; Cell Membrane; Cell Movement; Colorectal Neoplasms; Disease Progression; Dynamin II; Gene Expression Regulation, Neoplastic; Gold; HEK293 Cells; Humans; Matrix Metalloproteinase 14; Metal Nanoparticles; Neoplasm Invasiveness; Phosphorylation; Phosphotyrosine; Protein Binding; Pseudopodia; rac1 GTP-Binding Protein; Rho Guanine Nucleotide Exchange Factors; RNA, Messenger; src Homology Domains; Up-Regulation

2021
c-Src Promotes Tumorigenesis and Tumor Progression by Activating PFKFB3.
    Cell reports, 2020, 03-24, Volume: 30, Issue:12

    Topics: Animals; Carcinogenesis; Colonic Neoplasms; Disease Progression; Enzyme Activation; Glycolysis; HCT116 Cells; HEK293 Cells; Humans; Mice, Inbred C57BL; Mutation; Neoplasms; Phosphofructokinase-2; Phosphorylation; Phosphotyrosine; Protein Binding; Proto-Oncogene Proteins pp60(c-src); Reactive Oxygen Species

2020
Gastrin stimulates pancreatic cancer cell directional migration by activating the Gα12/13-RhoA-ROCK signaling pathway.
    Experimental & molecular medicine, 2018, 05-01, Volume: 50, Issue:5

    Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Polarity; Disease Progression; Focal Adhesions; Gastrins; Golgi Apparatus; GTP-Binding Protein alpha Subunits, G12-G13; Humans; Mice, Inbred BALB C; Mice, Nude; Models, Biological; Neoplasm Invasiveness; Organic Chemicals; Pancreatic Neoplasms; Paxillin; Phosphorylation; Phosphotyrosine; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction; Time Factors

2018
The ShcA PTB domain functions as a biological sensor of phosphotyrosine signaling during breast cancer progression.
    Cancer research, 2013, Jul-15, Volume: 73, Issue:14

    Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Disease Progression; Female; Fibronectins; Humans; Integrin alpha5beta1; Mammary Neoplasms, Experimental; Mice; Mice, Transgenic; Mutation; Neovascularization, Pathologic; Phosphotyrosine; Protein Structure, Tertiary; Receptor Protein-Tyrosine Kinases; Shc Signaling Adaptor Proteins; Signal Transduction; Vascular Endothelial Growth Factor A

2013
Germline variant FGFR4  p.G388R exposes a membrane-proximal STAT3 binding site.
    Nature, 2015, Dec-24, Volume: 528, Issue:7583

    Topics: Amino Acid Motifs; Amino Acid Sequence; Animals; Binding Sites; Breast Neoplasms; Cell Line; Cell Membrane; Disease Models, Animal; Disease Progression; Exons; Female; Gene Knock-In Techniques; Germ-Line Mutation; Humans; Lung Neoplasms; Male; Mice; Mice, Transgenic; Molecular Sequence Data; Phosphorylation; Phosphotyrosine; Polymorphism, Single Nucleotide; Receptor, Fibroblast Growth Factor, Type 4; Signal Transduction; STAT3 Transcription Factor

2015
A truncated phosphorylated p130Cas substrate domain is sufficient to drive breast cancer growth and metastasis formation in vivo.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016, Volume: 37, Issue:8

    Topics: Amino Acid Motifs; Animals; Breast Neoplasms; Cell Line, Tumor; Crk-Associated Substrate Protein; CSK Tyrosine-Protein Kinase; Disease Progression; Female; Genes, Reporter; Heterografts; Humans; MCF-7 Cells; Mice; Mice, Inbred NOD; Mice, SCID; Mice, Transgenic; Neoplasm Metastasis; Neoplasm Proteins; Peptide Fragments; Phosphorylation; Phosphotyrosine; Protein Domains; Protein Processing, Post-Translational; Recombinant Fusion Proteins; src-Family Kinases

2016
Cross talk between receptor guanylyl cyclase C and c-src tyrosine kinase regulates colon cancer cell cytostasis.
    Molecular and cellular biology, 2009, Volume: 29, Issue:19

    Topics: Amino Acid Sequence; Animals; Binding Sites; Cell Cycle; Cell Line, Tumor; Colonic Neoplasms; CSK Tyrosine-Protein Kinase; Disease Progression; Enzyme Activation; Guanylate Cyclase; Humans; Molecular Sequence Data; Phosphorylation; Phosphotyrosine; Protein-Tyrosine Kinases; Rats; Rats, Wistar; Receptors, Enterotoxin; Receptors, Guanylate Cyclase-Coupled; Receptors, Peptide; Sequence Alignment; src-Family Kinases

2009
Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Jun-20, Volume: 29, Issue:18

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Cohort Studies; Disease Progression; Disease-Free Survival; Drug Resistance, Neoplasm; Estrogen Receptor Modulators; Female; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Proteins; Nuclear Proteins; Phosphorylation; Phosphotyrosine; Prognosis; Protein Processing, Post-Translational; STAT5 Transcription Factor; Survival Analysis; Treatment Failure; Tumor Suppressor Proteins; Young Adult

2011
Tyrosine phosphate in melanoma progression.
    The British journal of dermatology, 2003, Volume: 149, Issue:2

    Topics: Disease Progression; Humans; Immunoenzyme Techniques; Melanocytes; Melanoma; Phosphorylation; Phosphotyrosine; Protein Tyrosine Phosphatases; Skin Neoplasms; Tumor Cells, Cultured

2003
TMF/ARA160 is a BC-box-containing protein that mediates the degradation of Stat3.
    Oncogene, 2004, Nov-25, Volume: 23, Issue:55

    Topics: Amino Acid Motifs; Amino Acid Sequence; Animals; Blotting, Western; Brain; Brain Neoplasms; Cell Line; Culture Media, Serum-Free; Cytoplasm; Disease Progression; DNA-Binding Proteins; Down-Regulation; Elongin; Golgi Apparatus; Golgi Matrix Proteins; Immunohistochemistry; Immunoprecipitation; Mice; Molecular Sequence Data; Phosphotyrosine; Plasmids; Proteasome Endopeptidase Complex; Protein Structure, Tertiary; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Sequence Homology, Amino Acid; STAT3 Transcription Factor; Time Factors; Trans-Activators; Transcription Factors; Transfection; Ubiquitin; Ubiquitin-Protein Ligases; Vesicular Transport Proteins

2004
Role of beta-arrestin 1 in the metastatic progression of colorectal cancer.
    Proceedings of the National Academy of Sciences of the United States of America, 2006, Jan-31, Volume: 103, Issue:5

    Topics: Arrestins; beta-Arrestin 1; beta-Arrestins; Blotting, Western; Cell Line, Tumor; Cell Membrane; Cell Movement; Collagen; Colorectal Neoplasms; CSK Tyrosine-Protein Kinase; Cytosol; Densitometry; Dinoprostone; Disease Progression; Drug Combinations; ErbB Receptors; Humans; Immunohistochemistry; Immunoprecipitation; Laminin; Microscopy, Fluorescence; Models, Biological; Neoplasm Metastasis; Phosphotyrosine; Protein-Tyrosine Kinases; Proteoglycans; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP4 Subtype; Signal Transduction; src-Family Kinases; Time Factors; Transcriptional Activation

2006
Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, May-15, Volume: 104, Issue:20

    Topics: Androgens; Animals; Cell Line, Tumor; Disease Progression; DNA, Neoplasm; Enhancer Elements, Genetic; Enzyme Activation; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Models, Genetic; Mutation; Neuregulin-1; Phosphorylation; Phosphotyrosine; Prostatic Neoplasms; Protein Binding; Protein Transport; Protein-Tyrosine Kinases; Receptor, ErbB-2; Receptors, Androgen; Transcription, Genetic; Transplantation, Heterologous

2007
Progressive loss of epidermal growth factor receptor in a subpopulation of breast cancers: implications in target-directed therapeutics.
    Molecular cancer therapeutics, 2007, Volume: 6, Issue:11

    Topics: Animals; Asian People; Breast Neoplasms; Cell Line, Tumor; Disease Progression; Drug Delivery Systems; Drug Resistance, Neoplasm; Enzyme Activation; ErbB Receptors; Female; Gefitinib; Gene Dosage; Humans; Mice; Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphoproteins; Phosphotyrosine; Proteomics; Quinazolines; Reproducibility of Results

2007
Fibroblast growth factor receptor 1 phosphotyrosine 766: molecular target for prevention of progression of prostate tumors to malignancy.
    Cancer research, 2002, Mar-15, Volume: 62, Issue:6

    Topics: Animals; Binding Sites; Cell Division; Cellular Senescence; Disease Progression; Isoenzymes; Male; MAP Kinase Signaling System; Phospholipase C gamma; Phosphorylation; Phosphotyrosine; Precancerous Conditions; Prostatic Neoplasms; Receptor Protein-Tyrosine Kinases; Receptor, Fibroblast Growth Factor, Type 1; Receptors, Fibroblast Growth Factor; Transcription, Genetic; Transfection; Type C Phospholipases

2002
Persistent defect in transmitter release and synapsin phosphorylation in cerebral cortex after transient moderate ischemic injury.
    Stroke, 2002, Volume: 33, Issue:5

    Topics: Animals; Calcium-Binding Proteins; Cerebral Cortex; Disease Progression; Glutamic Acid; Infarction, Middle Cerebral Artery; Ischemic Attack, Transient; Membrane Glycoproteins; Nerve Tissue Proteins; Neurons; Neurotransmitter Agents; Phosphorylation; Phosphotyrosine; Rats; Rats, Wistar; Synapsins; Synaptic Transmission; Synaptophysin; Synaptotagmins; Time

2002